 |
PDBsum entry 3p5b
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/lipid binding protein
|
PDB id
|
|
|
|
3p5b
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
92 a.a.
|
 |
|
|
|
|
|
|
|
493 a.a.
|
 |
|
|
|
|
|
|
|
394 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/lipid binding protein
|
 |
|
Title:
|
 |
The structure of the ldlr/pcsk9 complex reveals the receptor in an extended conformation
|
|
Structure:
|
 |
Proprotein convertase subtilisin/kexin type 9. Chain: p. Synonym: neural apoptosis-regulated convertase 1, narc-1, proprotein convertase 9, pc9, subtilisin/kexin-like protease pc9. Engineered: yes. Proprotein convertase subtilisin/kexin type 9. Chain: a. Synonym: neural apoptosis-regulated convertase 1, narc-1, proprotein convertase 9, pc9, subtilisin/kexin-like protease pc9.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: narc1, pcsk9, psec0052. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek293. Gene: ldlr, narc1, pcsk9, psec0052. Expression_system_cell_line: hek293
|
|
Resolution:
|
 |
|
3.30Å
|
R-factor:
|
0.271
|
R-free:
|
0.298
|
|
|
Authors:
|
 |
P.Lo Surdo,M.J.Bottomley,A.Calzetta,E.C.Settembre,A.Cirillo,S.Pandit, Y.Ni,B.Hubbard,A.Sitlani,A.Carfi
|
|
Key ref:
|
 |
P.Lo Surdo
et al.
(2011).
Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH.
Embo Rep,
12,
1300-1305.
PubMed id:
|
 |
|
Date:
|
 |
|
08-Oct-10
|
Release date:
|
26-Oct-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q8NBP7
(PCSK9_HUMAN) -
Proprotein convertase subtilisin/kexin type 9 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
692 a.a.
92 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Embo Rep
12:1300-1305
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH.
|
|
P.Lo Surdo,
M.J.Bottomley,
A.Calzetta,
E.C.Settembre,
A.Cirillo,
S.Pandit,
Y.G.Ni,
B.Hubbard,
A.Sitlani,
A.Carfí.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The protein PCSK9 (proprotein convertase subtilisin/kexin type 9) is a key
regulator of low-density lipoprotein receptor (LDLR) levels and cardiovascular
health. We have determined the crystal structure of LDLR bound to PCSK9 at
neutral pH. The structure shows LDLR in a new extended conformation. The PCSK9
C-terminal domain is solvent exposed, enabling cofactor binding, whereas the
catalytic domain and prodomain interact with LDLR epidermal growth factor(A) and
β-propeller domains, respectively. Thus, PCSK9 seems to hold LDLR in an
extended conformation and to interfere with conformational rearrangements
required for LDLR recycling.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |